Literature DB >> 16437728

Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease.

Maria Gazouli1, Gerassimos Mantzaris, Athanassios J Archimandritis, George Nasioulas, Nicholas P Anagnou.   

Abstract

AIM: To validate novel single nucleotide polymorphisms (SNPs) in Greek patients with Crohn's disease (CD).
METHODS: A total of 120 patients with CD, 85 patients with UC, and 100 unrelated healthy controls were genotyped. Genotyping was performed by allele-specific PCR or by PCR-RFLP analysis.
RESULTS: Our results showed that the 1672T and -207C alleles were obviously over-represented in CD patients only (P<0.01 and P<0.05, respectively) compared to the control population. The G113A polymorphism was completely absent in our studied population. The odds ratio for the carriage of the TC haplotype was 2.21 for CD patients as compared with controls. Additionally, the frequency of the TC haplotype was increased in patients with ileocolitis or colitis, and was mainly associated with the fibrostenotic phenotype of the disease. Furthermore, when the TC haplotype was compared jointly with the carriage of at least one mutation of the NOD2/CARD15 gene, there was an increased risk for CD, but not for UC, compared to controls. Regarding the location of the disease, the concomitant presence of the TC haplotype and NOD2/CARD15 mutations was mainly associated with ileocolitis or ileitis.
CONCLUSION: Collectively, our results suggest that the 1672T variant of the OCTN1 gene and the -207C variant of the OCTN2 gene represent risk factors for CD in the Greek population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437728      PMCID: PMC4725165          DOI: 10.3748/wjg.v11.i47.7525

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity.

Authors:  S R Brant; C I Panhuysen; J E Bailey-Wilson; P M Rohal; S Lee; J Mann; G Ravenhill; B S Kirschner; S B Hanauer; J H Cho; T M Bayless
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

2.  Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease.

Authors:  H Zouali; M Chamaillard; S Lesage; J P Cézard; J F Colombel; J Belaiche; S Almer; C Tysk; S Montague; M Gassull; S Christensen; Y Finkel; C Gower-Rousseau; R Modigliani; J Macry; H Selinger-Leneman; G Thomas; J P Hugot
Journal:  Eur J Hum Genet       Date:  2001-10       Impact factor: 4.246

3.  Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease.

Authors:  Muddassar M Mirza; Sheila A Fisher; Kathy King; Andrew P Cuthbert; Jochen Hampe; Jeremy Sanderson; John Mansfield; Peter Donaldson; Andrew J S Macpherson; Alastair Forbes; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Am J Hum Genet       Date:  2003-03-03       Impact factor: 11.025

Review 4.  The genetics of inflammatory bowel disease.

Authors:  Denise K Bonen; Judy H Cho
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

5.  Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease.

Authors:  Keiko Yamazaki; Masakazu Takazoe; Torao Tanaka; Toshiki Ichimori; Susumu Saito; Aritoshi Iida; Yoshihiro Onouchi; Akira Hata; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2004-10-19       Impact factor: 3.172

6.  Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation.

Authors:  W E Roediger; S Nance
Journal:  Br J Exp Pathol       Date:  1986-12

7.  Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.

Authors:  H-P Török; J Glas; L Tonenchi; P Lohse; B Müller-Myhsok; O Limbersky; C Neugebauer; F Schnitzler; J Seiderer; C Tillack; S Brand; G Brünnler; P Jagiello; J T Epplen; T Griga; W Klein; U Schiemann; M Folwaczny; T Ochsenkühn; C Folwaczny
Journal:  Gut       Date:  2005-06-14       Impact factor: 23.059

8.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Authors:  J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

9.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

10.  Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis.

Authors:  Dermot P B McGovern; David A Van Heel; Kenichi Negoro; Tariq Ahmad; Derek P Jewell
Journal:  Am J Hum Genet       Date:  2003-12       Impact factor: 11.025

View more
  15 in total

1.  Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Authors:  Jian Wang; Xi Wang; Hong Yang; Dong Wu; Li Wang; Jiaming Qian
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.

Authors:  Prem S Shekhawat; Sonne R Srinivas; Dietrich Matern; Michael J Bennett; Richard Boriack; Varghese George; Hongyan Xu; Puttur D Prasad; Penny Roon; Vadivel Ganapathy
Journal:  Mol Genet Metab       Date:  2007-09-19       Impact factor: 4.797

3.  IGR2096a_1 T and IGR2198a_1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn's disease in Hungarian patients.

Authors:  Lilla Lakner; Veronika Csöngei; Patrícia Sarlós; Luca Járomi; Eniko Sáfrány; Márta Varga; Péter Orosz; Lili Magyari; Judit Bene; Pál Miheller; Zsolt Tulassay; Béla Melegh
Journal:  Int J Colorectal Dis       Date:  2009-02-13       Impact factor: 2.571

4.  Haplotype in the IBD5 region is associated with refractory Crohn's disease in Slovenian patients and modulates expression of the SLC22A5 gene.

Authors:  Katja Repnik; Uroš Potočnik
Journal:  J Gastroenterol       Date:  2011-06-22       Impact factor: 7.527

5.  Enzymes involved in L-carnitine biosynthesis are expressed by small intestinal enterocytes in mice: implications for gut health.

Authors:  Prem S Shekhawat; Srinivas Sonne; A Lee Carter; Dietrich Matern; Vadivel Ganapathy
Journal:  J Crohns Colitis       Date:  2012-09-21       Impact factor: 9.071

6.  Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis.

Authors:  Chao Xuan; Bei-Bei Zhang; Tao Yang; Kai-Feng Deng; Ming Li; Rui-Juan Tian
Journal:  Int J Colorectal Dis       Date:  2011-06-25       Impact factor: 2.571

Review 7.  Role of discs large homolog 5.

Authors:  Frauke Friedrichs; Monika Stoll
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

8.  Prevalence of SLC22A4 1672T and SLC22A5 -207C combination defined TC haplotype in Hungarian ulcerative colitis patients.

Authors:  Lili Magyari; Judit Bene; Katalin Komlósi; Gábor Talián; Bernadett Faragó; Veronika Csöngei; Luca Járomi; Enikô Sáfrány; Csilla Sipeky; Lilla Lakner; Márta Varga; Beáta Gasztonyi; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

9.  Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis.

Authors:  Eniko Safrany; Melinda Szabo; Marta Szell; Lajos Kemeny; Katalin Sumegi; Bela I Melegh; Lili Magyari; Petra Matyas; Maria Figler; Agnes Weber; Zsolt Tulassay; Bela Melegh
Journal:  Inflamm Res       Date:  2012-10-25       Impact factor: 4.575

10.  Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).

Authors:  Sonne R Srinivas; Puttur D Prasad; Nagavedi S Umapathy; Vadivel Ganapathy; Prem S Shekhawat
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-13       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.